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ABSTRACT: Palladium-catalyzed oxidation of isopropyl N-acetyl-α-D-glucos-
amine (GlcNAc) is used to prepare the rare sugars allosamine, lividosamine,
and related compounds with unprecedented selectivity. The Passerini reaction
applied on 3-keto-GlcNAc provides an entry into branching of the carbon
skeleton in this compound.
■ INTRODUCTION
The hexoses glucose, galactose, mannose, glucosamine, and
rhamnose are commonly found in nature. They are part of
various O- and N-glycosylated proteins, glycolipids, and
glycans. Besides these hexoses, a large variety of rare sugars
have been isolated from natural sources. Altrose, allose, and
talose conﬁgured monosaccharides have been found in natural
products of bacteria in particular. Often these rare mono-
saccharides are also deoxygenated on one or multiple positions,
contain amino groups, and/or have a branched carbon
skeleton.1 The biological activity of the natural products
containing rare sugars necessitates the development of
synthesis routes that provide access to these sugars. These
less frequently occurring monosaccharides are generally
prepared from the readily available hexoses glucose, galactose,
mannose, and rhamnose.2 This nearly invariably comprises a
strategy that protects all-but-one hydroxyl groups, followed by
manipulation of the hydroxy group singled out, and ﬁnally
deprotection. Over the years this approach has reached a high
level of sophistication.3−5 Inversion of stereocenters has been
achieved by converting the singled out hydroxy group into the
sulfonate ester and subsequent nucleophilic substitution in
SN2-type fashion or by oxidation and subsequent stereo-
selective reduction.6a−d Preparation of deoxysugars from
protected carbohydrates involves either treatment of the
corresponding sulfonate ester7−9 (mesylate, tosylate, but
preferably triﬂate) with reactive hydride donors, radical
reduction of the corresponding halogen derivative or xanthate,
or desulfurization of the corresponding thiosugar.
The protecting group strategy has also been used to convert
glucosamine into allosamine; the C3-epimer of glucosamine,
and lividosamine, that is C3-deoxy glucosamine. Both
aminosugars, even though less frequently encountered in
nature than glucosamine, galactosamine, and mannosamine,
are certainly relevant. Allosamine forms the core component of
the Chitinase inhibitor allosamidin.10 Lividosamine is part of
the aminoglycosides lividomycin-A and -B and is a precursor
for the antibiotic thienamycin.11,12 As a building block for
novel antibiotics and inhibitors,13,14 ready access is highly
relevant all the more so because allosamine and lividosamine
are not commercially available. A downside of the reported
routes is that even for these apparently simple transformations,
epimerization of the hydroxyl group at C3 and deoxygenation,
the number of reaction steps, often involving puriﬁcation, is
already considerable.
With the current state of homogeneous catalysis, the
development and application of so-called site-selective catalysis
to prepare less accessible saccharides is an attractive strategy,
also to avoid the use of protecting groups.15 We and
Waymouth’s group have shown that site-selective palladium-
catalyzed oxidation of unprotected carbohydrates,16−21 includ-
ing glucose and N-acetyl glucosamine (Scheme 1), is highly
eﬃcient. The formed carbonyl function at C3 should be
amendable to several transformations without the requirement
to protect the remaining hydroxyl groups, though not at all a
trivial task considering the tendency of the carbonyl group to
enolize or form the corresponding hydrate. Nevertheless, we
considered this development an opportunity to gain a more
eﬃcient access to allosamine and lividosamine as well as
related diaminosugars and branched aminosugars that are
found in nature, mainly in bacteria.
We present here a route that is signiﬁcantly more eﬃcient, as
it makes protection of the C4 and C6 hydroxy groups obsolete.
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This approach is also used in a more eﬃcient synthesis of
lividosamine and an example of the use of unprotected
carbohydrates in the Passerini multicomponent reaction.
■ RESULTS AND DISCUSSION
To prepare allosamine, Jeanloz et al. inverted the stereocenter
at C3 in GlcNAc (Scheme 2).22 First GlcNAc was converted
into methyl-GlcNAc, and subsequently into its 4,6-benzylidene
derivative. Mesylation at C3 in a slow reaction is then followed
by SN2-substitution with acetate and hydrolysis to provide
methyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-allopyra-
noside. Hydrolysis of the benzylidene group results in methyl
N-acetyl-α-D-allosamine. Finally, hydrolysis with aqueous
hydrochloric acid provides allosamine. Alternatively, treatment
with silver acetate in acetic anhydride leads to N-acetyl-D-
allosamine. Even though this route reported by Jeanloz in 1957
is laborious, it still appears to be the method of choice. The
alternative routes to prepare allosamine that have been
reported over the years occasionally have comparable or
somewhat higher yields, but the step-count is invariably higher
also because the required starting materials are not available
and therefore have to be prepared.23−25
For the synthesis of lividosamine, GlcNAc is deoxygenated
at C3. Arguably the most eﬃcient procedure to lividosamine
(2,3-dideoxy-2-aminoglucose) currently is the approach
reported by Zhao et al.26 GlcNAc is converted into the
corresponding isopropylidene protected furanosyl oxazoline,
and the C3 hydroxy group is converted into a xanthate,
followed by radical deoxygenation with Bu3SnH, and ﬁnally
hydrolysis to provide lividosamine.27a−f
We ﬁrst focused our attention on the synthesis of allosamine
by site-selective oxidation followed by stereoselective reduc-
tion. Although our palladium-catalyzed oxidation is eﬀective on
the parent GlcNAc,19 subsequent reduction with NaBH4 is not
selective toward N-acetyl allosamine, whereas reduction of the
corresponding α-methyl analogue is. L-Selectride was eﬀective
for the stereoselective reduction of 3-ketoglucose,19 but
subsequent puriﬁcation was not straightforward. As we desired
Scheme 1. Site-Selective Palladium-Catalyzed Oxidation of Unprotected Carbohydrates
Scheme 2. Jeanloz Synthesis of D-Allosamine and D-N-Acetyl Allosamine
Scheme 3. Synthesis of D-Allosamine and N-Acetyl-D-allosamine
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preparative amounts of allosamine, the reduction of 3-keto-
GlcNAc with L-selectride was discarded. Attempts to oxidize
methyl α-D-glucosamine in which the amino group was
protected by protonation failed; no reaction was observed.
Fischer glycosylation of GlcNAc with methanol aﬀords an
anomeric mixture with a 9.8 to 1 ratio of the α and β anomers
of 2, respectively (see SI Scheme S1 for compounds 2 and 4
and an X-ray structure of 4), but removal of the β-anomer of 2
by column chromatography is diﬃcult. Carrying out the
reaction with isopropyl alcohol gave a comparable α to β ratio
of 9 to 1, but in this case, the anomeric mixture was readily
separated by column chromatography. We observed in a later
stage (vide infra) that the reduction of the C3 carbonyl in the
α-isopropyl analogue was slightly more stereoselective.
Oxidation of the β-anomer of isopropyl N-acetyl-D-glucos-
amine and subsequent reduction was, as expected, considerably
less selective and aﬀorded a 2:1 mixture of the gluco- and allo-
conﬁgured products (see SI). This observation made
Figure 1. X-ray structure of boc-hydrazone 24.
Scheme 4. Synthesis of D-Lividosamine
Scheme 5. Synthesis of 2,3-Di-amino Glucose and a Corresponding Fused Imidazole
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isopropyl-α-GlcNAc 6 the starting material of choice (Scheme
3). In addition, benzyl-α-GlcNAc 9 was prepared as the benzyl
substituent and can be removed with mild hydrogenolysis
(Scheme 3).
Catalytic oxidation proceeded smoothly to produce ketone 7
in 89% yield. Its structure was conﬁrmed by X-ray crystal
analysis of the corresponding Boc-hydrazone 24 (Figure 1, see
also SI). Triﬂuoroethanol was chosen as the solvent for this
reaction, according to Waymouth et al.,21 as it is more readily
removed compared to DMSO. Subsequent NaBH4 reduction
provided isopropyl N-acetyl allosamine in a 98 to 2 allo to
glucose ratio, the latter being readily removed by column
chromatography. Hydrolysis under acidic conditions provided
allosamine in 92% yield. Overall, this route provides pure
allosamine in 4 steps, 49% yield, a signiﬁcant improvement in
yield and stepcount compared to the existing procedures; also
compared to the one of Jeanloz, as in that procedure, the
starting material requires an additional two steps. When the
synthesis was carried out with the benzyl analogue, hydro-
genolysis aﬀorded N-acetyl allosamine 12 in 41% overall yield.
We next focused our attention on the synthesis of
lividosamine. We reasoned that deoxygenation of the carbonyl
function in 7, in the presence of hydroxyl groups, would lead
directly to isopropyl N-acetyl lividosamine 15. The number of
reactions that converts ketones directly into the corresponding
methylene group is limited, and the most appropriate one in
the current situation seemed a Caglioti-type reaction, that is,
reduction of the corresponding tosylhydrazone.28 This
reaction, however, had not been applied on unprotected
carbohydrates. As expected, synthesis of the tosylhydrazone
was uneventful. We were pleased to see that subsequent
reduction with NaCNBH3 in methanol and tetrahydrofuran
under slightly acidic conditions, followed by elimination with
NaOAc provided 15 (isopropyl 2,3-dideoxy-2-N-acetyl glucos-
amine). Subsequent hydrolysis provided lividosamine (Scheme
4). Our route to lividosamine is not more eﬃcient than the one
of Zhao et al.,26 but it does avoid the use of tin reagents and
applies the same building block as the synthesis of allosamine.
We had shown earlier in the glucose series that reductive
amination of the C3 carbonyl provides an eﬃcient route to 3-
amino glucose.16 Here, we used this strategy on 3-keto GlcNAc
7 as well. Synthesis of the methyl oxime 17 (formed as a 1:1
mixture of E and Z isomers) was followed by hydrogenolysis/
hydrogenation with Adams’ catalyst and hydrogen (Scheme 5).
This provided the axially oriented 3-amino group, as expected,
because of the shielding by the anomeric isopropyl substituent.
After hydrolysis of the acetamide, 2,3-dideoxy-2,3-diaminoal-
lose 19 is obtained. As an illustration that this compound, next
to being valuable itself, is a suitable building block for
heterocycle synthesis, 19 was condensed with benzaldehyde to
provide imidazoline 20. Subsequent oxidation with PIDA
provides the corresponding imidazole 21. Remarkably,
compounds with this or related scaﬀolds have hardly been
reported29 and are therefore a viable addition to the “chemical
space” used in medicinal chemistry.
Carbon−carbon bond formation reactions involving un-
protected carbohydrates have recently received attention due
to the work of Mahrwald et al.30 Our group reported on site-
selective carbon−carbon bond formation in unprotected
monosaccharides at C3 using photoredox catalysis that allows
the formation of branched scaﬀolds.31 Furthermore, we have
shown that overoxidation during the palladium-catalyzed
oxidation results in branched scaﬀolds as well.19 Also
nucleophilic attack of carbon nucleophiles at the carbonyl
function in 7 falls in this class.32−34 Here we present the use of
the multicomponent Passerini reaction in this context.
Treatment of 7 with benzyl isocyanide and benzoic acid in
THF/DCM (1:1, 1 M) provided the expected 3-acyloxy
Passerini product 22a. NMR analysis of this product showed
that it had the indicated stereochemistry. Presumably, the
shielding by the anomeric isopropyl substituent blocks attack
from the bottom face and thus prevents the formation of the
other epimer. In addition to 22a, we isolated a second product
22b, which revealed to be a regioisomer of 22a (Scheme 6).
The formation of 22b may be explained by the mechanism of
Passerini reaction. During the reaction, a reactive O-acyl
imidate intermediate is formed. This intermediate acylates a
neighboring hydroxyl group. Normally, the newly formed
hydroxy group is the only that qualiﬁes for acyl transfer, but in
our case, both the C3OH and the C4OH are in proximity.
Hydrolysis of the product 22a and 22b, respectively, provided
the same product 23 (Scheme 6).
■ CONCLUSION
Site-selective catalytic oxidation of GlcNAc is the key step in
novel entries to several rare aminosugars and related building
blocks. This study shows that unprotected carbohydrates, in
Scheme 6. Passerini Reaction with 1-Isopropyl-3-keto GlcNAc
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the present case GlcNAc, are more amendable to selective
modiﬁcation and conversion than generally assumed and that
with a careful selection of reaction conditions, many
transformations, in the presence of several free hydroxyl
groups, are possible.
■ EXPERIMENTAL SECTION
General Information. All solvents used for reaction, extraction,
ﬁltration, and chromatography were of commercial grade and used
without further puriﬁcation. [(neocuproine)Pd(μ-OAc)]2(OTf)2 was
prepared according to the literature procedure.35 Flash chromatog-
raphy was performed on a Reveleris X2 Flash Chromatography, using
Grace Reveleris Silica ﬂash cartridges (4 g, 12 g, 15 g, 24 g, 40 g, 80 g,
and 120 g) and Scorpius Diol (OH) 48 g. 1H-, 13C-, APT-, HSQC-,
and COSY-NMR were recorded on a Varian AMX400 spectrometer
(400, 100 MHz, respectively) using DMSO-d6, D2O, or methanol-d4
as solvent. Chemical shift values are reported in ppm with the solvent
resonance as the internal standard (DMSO-d6: δ 2.50 for
1H, δ 39.52
for 13C, CD3OD: δ 3.31 for
1H, δ 49.15 for 13C; D2O: δ 4.80 for
1H).
Data are reported as follows: chemical shifts (δ), multiplicity (s =
singlet, d = doublet, dd = double doublet, ddd = double double
doublet, t = triplet, appt = apparent triplet, q = quartet, m =
multiplet), coupling constants J (Hz), and integration. High-
resolution mass measurements were performed using a Thermo-
Scientiﬁc LTQ OribitrapXL spectrometer.
Compound Synthesis and Characterization. Methyl 2-
Acetamido-2-deoxy-α-D-glucopyranoside (2). A suspension of N-
acetyl glucosamine (10 g, 0.045 mol) and dry Amberlite IR 120H+
(12 g) in MeOH (300 mL) was heated at reﬂux for 48 h. Upon
cooling, the Amberlite resin was removed by ﬁltration, and the
methanol removed in vacuo to provide the product 9.98 g as a
mixture of α and β, yield: 94%, as a white solid (α:β = 9.8:1). Five g of
this mixture was puriﬁed by ﬂash chromatography on a 120 g silica
cartridge with DCM/MeOH, and increasing ratio of MeOH from 0 to
20% in 50 min, the product eluted at 14% MeOH to aﬀord pure
methyl 2-acetamido-2-deoxy-D-glucopyranoside as white solid (2.37 g,
yield: 47%) mp 188−189 °C (lit.36 186−188 °C); 1H NMR (400
MHz, methanol-d4) δ 4.65 (d, J = 3.5 Hz, 1H), 3.90 (dd, J = 10.7, 3.6
Hz, 1H), 3.83 (dd, J = 11.9, 2.4 Hz, 1H), 3.69 (dd, J = 11.9, 5.7 Hz,
1H), 3.63 (dd, J = 10.7, 8.7 Hz, 1H), 3.54 (ddd, J = 10.0, 5.7, 2.4 Hz,
1H), 3.37 (s, 3H), 3.36−3.32 (m, 1H), 1.98 (s, 3H); 13C{1H} NMR
(101 MHz, methanol-d4) δ 173.8, 100.0, 73.8, 73.1, 72.5, 62.9, 55.6,
55.5, 22.7. HRMS (ESI-TOF) m/z: [M + H]+ and [M + Na]+ Calcd
for C9H18NO6 236.1129 and C9H17NO6Na 258.0954; found
236.1132 and 258.0953.
Methyl 2-Acetamido-2-deoxy-α-D-glucopyran-3-ulose (3). Meth-
yl 2-acetamido-2-deoxy-α-D-glucopyranoside 2 (474 mg, 2 mmol) and
benzoquinone (324 mg, 3 mmol) were dissolved in DMSO (6.6 mL).
The catalyst [(neocuproine)PdOAc]2OTf2 (57 mg, 2.5 mol %) was
added, and the mixture was stirred at room temperature for 1 h. Upon
completion of the reaction (according to TLC), water (70 mL) was
added, and the mixture was lyophilized to aﬀord the crude product.
Subsequent puriﬁcation by ﬂash chromatography on a 12 g silica
cartridge with DCM/MeOH, increasing ratio of MeOH from 0 to 7%
in 21 min, the product eluted at 4% MeOH to aﬀord a white solid
(346 mg, 74%), mp 161−162 °C (lit.36 164 °C); 1H NMR (400
MHz, Methanol-d4) δ 5.09 (d, J = 4.1 Hz, 1H), 4.88 (dd, J = 4.1, 1.2
Hz, 1H), 4.29 (dd, J = 9.8, 1.3 Hz, 1H), 3.89 (dd, J = 12.1, 2.3 Hz,
1H), 3.82 (dd, J = 12.1, 4.6 Hz, 1H), 3.73−3.67 (m, 1H), 3.39 (s,
3H), 2.03 (s, 3H); 13C{1H} NMR (101 MHz, methanol-d4) δ 203.8,
173.7, 102.4, 77.0, 73.8, 62.6, 60.3, 55.8, 22.4; HRMS (ESI-TOF) m/
z: [M + H]+ and [M + Na]+ Calcd for C9H16NO6 234.0972 and
C9H15NO6Na 256.0797; found 234.0973 and 256.0793.
Methyl 2-Acetamido-2-deoxy-α-D-allopyranoside (4). Methyl 2-
acetamido-2-deoxy-α-D-glucopyran-3-ulose 3 (346 mg, 1.5 mmol) was
dissolved in MeOH (12 mL), and the mixture was cooled to 0 °C.
NaBH4 (170 mg, 4.5 mmol) was added, and the mixture stirred for 1
h at 0 °C. Upon completion of the reaction, Amberlite 120 H+ was
added until pH ∼ 7, as indicated by pH paper to quench remaining
NaBH4. Subsequent ﬁltration and removal of the solvent in vacuo
aﬀorded the crude product. This was puriﬁed by ﬂash chromatog-
raphy on a 12 g silica cartridge with DCM/MeOH, and increasing
ratio of MeOH from 0 to 20% in 21 min, the product eluted at 10%
MeOH to aﬀord a brown oil (295 mg, 85%); the product elutes as the
mixture of methyl 2-acetamido-2-deoxy-α-D-allopyranoside and
methyl 2-acetamido-2-deoxy-α-D-glucopyranoside (96:4), which is
diﬃcult to be separated by silica chromatography. 1H NMR (400
MHz, methanol-d4) δ 4.67 (d, J = 3.9 Hz, 1H), 4.05 (t, J = 3.6 Hz,
1H), 3.92 (t, J = 3.3 Hz, 1H), 3.86 (dd, J = 11.3, 1.7 Hz, 1H), 3.80−
3.69 (m, 2H), 3.53 (dd, J = 9.8, 3.2 Hz, 1H), 3.40 (s, 3H), 2.01 (s,
3H); 13C{1H} NMR (101 MHz, methanol-d4) δ 173.1, 99.9, 71.5,
69.1, 68.3, 62.9, 56.1, 51.7, 22.7; HRMS (ESI-TOF) m/z: [M + H]+
and [M + Na]+ Calcd for C9H18NO6 236.1129 and C9H17NO6Na
258.0954; found 236.1130 and 258.0950
D-Allosamine (5). Methyl 2-acetamido-2-deoxy-α-D-allopyranoside
4 (295 mg, 1.2 mmol) was dissolved in HClaq (2 M, 1.5 mL) and
heated at 100 °C for 2 h. Subsequent evaporation of the volatiles
provided allosamine·HCl (236 mg, 87%) as a brown syrup. Spectral
data were identical to those obtained by hydrolysis of isopropyl N-
acetyl-α-D-allosamine.
Isopropyl 2-Acetamido-2-deoxy-α-D-glucopyranoside (6). Acetyl
chloride (1.93 mL, 27.12 mmol) was slowly added to a suspension of
N-acetyl-D-glucosamine (4.0 g, 18.08 mmol) in isopropyl alcohol (160
mL) at room temperature. The suspension was subsequently heated
to reﬂux. The solid dissolved gradually. After 2 h, reaction was
ﬁnished (according to TLC). At room temperature, NaHCO3 was
added until pH ∼ 7, and the mixture was stirred for 1 h. Upon
ﬁltration and evaporation of the solvent, puriﬁcation was carried out
by ﬂash chromatography on a 120 g silica cartridge with DCM/
MeOH, and increasing ratio of MeOH from 0 to 15% in 38 min, the
product eluted at 9% MeOH to aﬀord a white solid (3.49 g, 77%),
m.p.: 182−184 °C (lit.37 187−189 °C); 1H NMR (400 MHz,
methanol-d4) δ 4.90 (d, J = 3.7 Hz, 1H), 3.93−3.76 (m, 3H), 3.71−
3.61 (m, 3H), 3.37−3.32 (m, 1H), 1.97 (s, 3H), 1.22 (d, J = 6.2 Hz,
3H), 1.12 (d, J = 6.2 Hz, 3H); 13C{1H} NMR (101 MHz, methanol-
d4) δ 173.7, 96.8, 73.9, 72.8, 72.6, 71.2, 62.9, 55.7, 23.8, 22.7, 21.8;
HRMS (ESI-TOF) m/z: [M + H]+ and [M + Na]+ Calcd for
C11H22NO6 264.1442 and C11H21NO6Na 286.1267; found 264.1445
and 286.1265.
Isopropyl 2-Acetamido-2-deoxy-α-D-glucopyran-3-uloside (7).
Isopropyl 2-acetamido-2-deoxy-α-D-glucopyranoside 6 (3.33 g, 12.65
mmol) and benzoquinone (2.05 g, 18.97 mmol) were dissolved in
2,2,2-triﬂuoroethanol (126 mL). The catalyst [(neocuproine)Pd(μ-
OAc)]2(OTf)2 (133 mg, 1 mol %) was added, and the mixture was
stirred at 60 °C for 1 h. Next, the solvent was evaporated, and the
crude product was puriﬁed by ﬂash chromatography on a 80 g silica
cartridge with pentane/EtOAc, and increasing ratio of EtOAc from 0
to 100%, the product eluted at 88% of EtOAc to aﬀord a white solid
(2.95 g, 89%), m.p.: 125−126 °C; 1H NMR (400 MHz, methanol-d4)
δ 5.34 (d, J = 4.2 Hz, 1H), 4.86 (dd, J = 4.4, 1.3 Hz, 1H), 4.28 (dd, J
= 9.0, 1.3 Hz, 1H), 3.93 (p, J = 6.2 Hz, 1H), 3.89−3.79 (m, 3H), 2.03
(s, 3H), 1.19 (d, J = 6.3 Hz, 3H), 1.13 (d, J = 6.1 Hz, 3H); 13C{1H}
NMR (101 MHz, methanol-d4) δ 203.9, 173.5, 99.5, 77.2, 73.9, 71.8,
62.7, 60.4, 23.5, 22.4, 21.6; HRMS (ESI-TOF) m/z: [M + H]+ and
[M + Na]+ Calcd for C11H20NO6 262.1285 and C11H19NO6Na
284.1110 ; found: 262.1287 and 284.1106.
Isopropyl 2-Acetamido-2-deoxy-β-D-glucopyran-3-uloside (25).
This product was prepared as described for the α anomer starting
from isopropyl 2-acetamido-2-deoxy-β-D-glucopyranoside. 1H NMR
(400 MHz, methanol-d4) δ 4.66 (d, J = 8.3 Hz, 1H), 4.48 (d, J = 8.3
Hz, 1H), 4.22 (d, J = 10.1 Hz, 1H), 4.08−3.99 (m, 1H), 3.94 (dd, J =
12.3, 2.2 Hz, 1H), 3.80 (dd, J = 12.1, 5.0 Hz, 1H), 3.40−3.34 (m,
1H), 2.02 (s, 3H), 1.24 (d, J = 6.1 Hz, 3H), 1.14 (d, J = 6.1 Hz, 3H).
13C{1H} NMR (101 MHz, methanol-d4) δ 204.2, 173.6, 102.4, 78.1,
74.2, 73.5, 62.9, 62.8, 23.8, 22.6, 22.3. HRMS (ESI-TOF) m/z: [M +
Na]+ Calcd for C11H19NO6Na 284.1105; found 284.1108.
Isopropyl 2-Acetamido-2-deoxy-α-D-allopyranoside (8). Isoprop-
yl 2-acetamido-2-deoxy-α-D-glucopyran-3-uloside 7 (2.0 g, 7.66
mmol) was dissolved in MeOH (50 mL), and the mixture was
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cooled to 0 °C. NaBH4 (434 mg, 11.48 mmol) was added, and the
mixture was stirred for 30 min at 0 °C. Upon completion of the
reaction, methanolic HCl (2 M) was added slowly until pH ∼ 7, as
indicated by pH paper to quench remaining NaBH4. The ratio of
isopropyl 2-acetamido-2-deoxy-α-D-allopyranoside and isopropyl 2-
acetamido-2-deoxy-α-D-glucopyranoside is approximately 98:2. Puri-
ﬁcation by ﬂash chromatography on a 40 g silica cartridge with DCM/
MeOH, increasing ratio of MeOH from 0 to 15% in 29 min, pure
isopropyl 2-acetamido-2-deoxy-α-D-allopyranoside eluted at 7%
MeOH to aﬀord a white semisolid (1.56 g, 77%); 1H NMR (400
MHz, methanol-d4) δ 4.94 (d, J = 3.9 Hz, 1H), 4.02 (app t, J = 3.6 Hz,
1H), 3.98−3.91 (m, 1H), 3.89 (t, J = 3.3 Hz, 1H), 3.87−3.81 (m,
2H), 3.76−3.70 (m, 1H), 3.53 (dd, J = 10.0, 3.2 Hz, 1H), 2.02 (s,
3H), 1.26 (d, J = 6.3 Hz, 3H), 1.15 (d, J = 6.1 Hz, 3H); 13C{1H}
NMR (101 MHz, methanol-d4) δ 173.2, 97.1, 72.1, 72.0, 69.4, 68.4,
62.9, 51.6, 23.8, 22.6, 21.6. HRMS (ESI-TOF) m/z: [M + H]+ and
[M + Na]+ Calcd for C11H22NO6 264.1442 and C11H21NO6Na
286.1267; found 264.1443 and 286.1263.
Isopropyl 2-Acetamido-2-deoxy-β-D-allopyranoside (26). Iso-
propyl 2-acetamido-2-deoxy-β-D-glucopyran-3-uloside (25) was re-
duced as described for the α anomer. A 1 to 2 mixture of the allo and
gluco conﬁgured product was obtained. 1H NMR (400 MHz,
methanol-d4) δ 4.75 (d, J = 8.5 Hz, 1H), 4.02−3.91 (m, 2H), 3.84
(dd, J = 11.4, 2.0 Hz, 1H), 3.79 (dd, J = 8.5, 2.9 Hz, 1H), 3.76−3.66
(m, 1H), 3.66 (dd, J = 11.3, 5.7 Hz, 1H), 3.51 (dd, J = 9.5, 3.0 Hz,
1H), 1.98 (s, 3H), 1.19 (d, J = 6.2 Hz, 3H), 1.13 (d, J = 6.1 Hz, 3H).
13C{1H} NMR (101 MHz, Methanol-d4) δ 173.1, 99.1, 75.6, 73.0,
71.8, 68.9, 63.4, 55.0, 24.0, 22.8, 22.4. HRMS (ESI-TOF) m/z: [M +
Na]+ Calcd for C11H21NO6Na 286.1261; found 286.1264.
Isopropyl 2-Acetamido-2-deoxy-β-D-glucopyranoside (27). 1H
NMR (400 MHz, methanol-d4) δ 4.50 (d, J = 8.0 Hz, 1H), 3.96 (p, J
= 6.2 Hz, 1H), 3.87 (dd, J = 11.9, 2.2 Hz, 1H), 3.68 (dd, J = 11.9, 5.6
Hz, 1H), 3.59−3.46 (m, 2H), 3.34−3.23 (m, 3H), 1.97 (s, 3H), 1.19
(d, J = 6.2 Hz, 3H), 1.12 (d, J = 6.1 Hz, 3H). 13C{1H} NMR (101
MHz, methanol-d4) δ 173.8, 101.3, 78.0, 76.1, 73.1, 72.3, 63.0, 57.9,
23.9, 23.1, 22.4.
D-Allosamine (5). Isopropyl 2-acetamido-2-deoxy-α-D-allopyrano-
side 8 (1.53 g, 5.81 mmol) was dissolved in HCl aq (2 M, 7.0 mL)
and heated at 100 °C for 2 h. Subsequent evaporation of the volatiles
provided the product (1.16 g, 92%) as a brown syrup. The product
comes as a mixture of pyranose and furanose forms, the major form
being the β-pyranose. The 1H NMR of D-allosamine as reported in the
literature38 is in D2O, and we found that the use of methanol-d4 gives
a much higher quality spectrum. 1H NMR (400 MHz, methanol-d4) δ
5.03 (d, J = 8.3 Hz, 1H), 4.16 (t, J = 3.0 Hz, 1H), 3.85 (dd, J = 11.7,
2.3 Hz, 1H), 3.80−3.73 (m, 1H), 3.71−3.65 (m, 1H), 3.56 (dd, J =
9.8, 2.9 Hz, 1H), 3.01 (dd, J = 8.4, 2.9 Hz, 1H); 13C{1H} NMR (101
MHz, Methanol-d4) δ 92.6, 75.9, 69.6, 68.5, 63.0, 56.4; HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C6H14NO5 180.0867; found
180.0868.
Benzyl 2-Acetamido-2-deoxy-α-D-glucopyranoside (9). Acetyl
chloride (1.9 mL, 27.1 mmol) was slowly added to the suspension
of N-acetyl glucosamine (4.0 g, 18.08 mmol) in benzyl alcohol (40
mL) and stirred at room temperature for 30 min. The mixture was
then heated to 95 °C. After 3 h, the reaction mixture was allowed to
cool down at room temperature, followed by the addition of
anhydrous Na2SO4 (257 mg, 1.81 mmol). Subsequently the reaction
was heated to 75 °C for 3 h before being cooled to room temperature.
The resulting brown solution was slowly poured into Et2O (700 mL).
The precipitate was recovered by ﬁltration and puriﬁed by ﬂash
chromatography on a 120 g silica cartridge with DCM/MeOH, and
increasing the ratio of MeOH from 0 to 15% in 38 min, the product
eluted at 9% MeOH to aﬀord a white solid (3.28 g, 58%), m.p.: 175−
177 °C (lit.39 178−180 °C); 1H NMR (400 MHz, methanol-d4) δ
7.43−7.23 (m, 5H), 4.86 (1H, overlap with the peak of CD3OD),
4.75 (d, J = 12.0 Hz, 1H), 4.50 (d, J = 12.0 Hz, 1H), 3.89 (dd, J =
10.7, 3.6 Hz, 1H), 3.87−3.78 (m, 1H), 3.76−3.62 (m, 3H), 3.42−
3.32 (m, 1H), 1.95 (s, 3H); 13C{1H} NMR (101 MHz, methanol-d4)
δ 173.7, 139.2, 129.5, 129.4, 129.0, 97.6, 74.2, 72.8, 72.6, 70.3, 62.9,
55.6, 22.7; HRMS (ESI-TOF) m/z: [M + H]+ and [M + Na]+ Calcd
for C15H22NO6 312.1442 and C15H21NO6Na 334.1267; found
312.1446 and 334.1264.
Benzyl 2-Acetamido-2-deoxy-α-D-glucopyran-3-uloside (10).
Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside 9 (1.28 g, 4.11
mmol) and benzoquinone (667 mg, 6.17 mmol) were dissolved in
2,2,2-triﬂuoroethanol (41 mL). The catalyst [(2,9-dimethyl-1,10-
phenanthroline)-Pd(μ-OAc)]2(OTf)2 (43 mg, 1 mol %) was added,
and the mixture was stirred at 60 °C for 1 h. Subsequently the solvent
was evaporated, and the crude was puriﬁed by ﬂash chromatography
on a 40 g silica cartridge with pentane/EtOAc, and increasing the
ratio of EtOAc from 0 to 100% in 29 min, the product eluted at 100%
EtOAc to aﬀord a white solid (1.16 g, 91%), m.p.: 124−126 °C; 1H
NMR (400 MHz, methanol-d4) δ 7.38−7.24 (m, 5H), 5.27 (d, J = 4.2
Hz, 1H), 4.91 (dd, J = 4.2, 1.3 Hz, 1H), 4.73 (d, J = 12.0 Hz, 1H),
4.55 (d, J = 12.0 Hz, 1H), 4.31 (dd, J = 9.4, 1.3 Hz, 1H), 3.91−3.76
(m, 3H), 2.00 (s, 3H); 13C{1H} NMR (101 MHz, methanol-d4) δ
203.7, 173.5, 138.4, 129.6, 129.5, 129.2, 100.2, 77.5, 73.9, 70.6, 62.6,
60.3, 22.4; HRMS (ESI-TOF) m/z: [M + H]+ and [M + Na]+ Calcd
for C15H20NO6 310.1285 and C15H19NO6Na 332.1110; found
310.1289 and 332.1107.
Benzyl 2-Acetamido-2-deoxy-α-D-allopyranoside (11). Benzyl 2-
acetamide-2-deoxy-α-D-glucopyran-3-uloside 10 (935 mg, 3.02 mmol)
was dissolved in MeOH (50 mL), and the mixture was cooled to 0
°C. NaBH4 (172 mg, 4.53 mmol) was added to the mixture, and the
mixture was stirred for 30 min at 0 °C. Upon completion of the
reaction, methanolic HCl (2 M) was added slowly until the pH
reached around 7 (as indicated by pH paper) to quench remaining
NaBH4. The ratio of benzyl 2-acetamido-2-deoxy-α-D-allopyranoside
and benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside is approxi-
mately 96:4. Subsequently, solvents were evaporated, and the crude
puriﬁed by ﬂash chromatography on a 24 g silica cartridge with
EtOAc/MeOH, and increasing ratio of MeOH from 0 to 15% in 21
min, the product eluted at 7% MeOH to aﬀord a white solid (742 mg,
79%), m.p.: 144−145 °C; 1H NMR (400 MHz, methanol-d4) δ 7.43−
7.38 (m, 2H), 7.38−7.26 (m, 3H), 4.86 (overlap with H2O in
CD3OD, 1H), 4.78 (d, J = 12.1 Hz, 1H), 4.54 (d, J = 12.1 Hz, 1H),
4.06 (t, J = 3.7 Hz, 1H), 3.92 (t, J = 3.3 Hz, 1H), 3.89−3.82 (m, 2H),
3.73 (dd, J = 12.0, 5.7 Hz, 1H), 3.55 (dd, J = 10.2, 3.2 Hz, 1H), 1.98
(s, 3H); 13C{1H} NMR (101 MHz, methanol-d4) δ 173.0, 139.0,
129.6, 129.5, 129.1, 97.5, 71.6, 70.7, 69.5, 68.4, 62.9, 51.6, 22.6;
HRMS (ESI-TOF) m/z: [M + H]+ and [M + Na]+ Calcd for
C15H22NO6 312.1442 and C15H21NO6Na 334.1267; found 312.1446
and 334.1265.
N-Acetyl-D-allosamine (12). To a solution of benzyl 2-acetamido-
2-deoxy-α-D-allopyranoside 11 (673 mg, 2.16 mmol) in H2O (50 mL)
was added 415 mg of 10% Pd/C (supplied by Alfa Aesar, Type 487).
The atmosphere was changed to hydrogen (balloon), and the mixture
was stirred overnight. The catalyst was removed by ﬁltration, and the
ﬁltrate was concentrated to aﬀord the product (472 mg, 99%) as a
white ﬂuﬀy solid. The product comes as a mixture of pyranose and
furanose forms, the major form being the β-pyranose. The 1H NMR is
consistent with the literature;40 1H NMR (400 MHz, D2O) δ 4.97 (d,
J = 8.7 Hz, 1H), 4.11 (t, J = 2.9 Hz, 1H), 3.91 (dd, J = 12.1, 2.2 Hz,
1H), 3.86−3.82 (m, 1H), 3.82−3.78 (m, 1H), 3.75 (dd, J = 12.6, 6.8
Hz, 1H), 3.70 (dd, J = 10.1, 3.0 Hz, 1H), 2.07 (s, 3H); 13C{1H} NMR
(101 MHz, D2O) δ 174.0, 92.3, 73.7, 69.6, 66.4, 61.1, 54.2, 21.8;




mixture of isopropyl 2-acetamide-2-deoxy-α-D-ribo-hexapyranoside-3-
ulose 7 (695 mg, 2.66 mmol) and p-toluenesulfonyl hydrazide (743
mg, 3.99 mmol) in absolute ethanol (2.6 mL) was heated at 70 °C for
3 h and stirred for 24 h at room temperature. Then acetic acid (152
μL, 2.66 mmol) was added to the reaction mixture. After 5 h, a second
portion of acetic acid (152 μL, 2.66 mmol) was added, and the
reaction mixture was stirred for another 24 h until the reaction
completed (monitored by TLC). The solvent was evaporated, and the
product was puriﬁed by ﬂash chromatography on a 24 g silica
cartridge with DCM/MeOH, and increasing the ratio of MeOH from
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0 to 4% in 22 min, the product eluted at 3% MeOH to provide a
yellow oil (1.06 g, 93%). 1H NMR (400 MHz, methanol-d4) δ 7.74
(d, J = 8.1 Hz, 2H), 7.62 (d, J = 8.1 Hz, 1H, −SO2NH−), 7.38 (d, J =
8.0 Hz, 2H), 5.04 (d, J = 3.6 Hz, 1H), 4.50−4.43 (m, 2H), 3.84 (p, J
= 6.2 Hz, 1H), 3.80−3.74 (m, 1H), 3.73−3.66 (m, 2H), 2.42 (s, 3H),
2.04 (s, 3H), 1.12 (d, J = 6.3 Hz, 3H), 1.07 (d, J = 6.1 Hz, 3H);
13C{1H} NMR (101 MHz, methanol-d4) δ 173.2, 173.1, 148.8, 148.7,
145.6, 137.3, 130.9, 128.7, 97.7, 75.7, 73.4, 71.7, 61.9, 55.4, 23.6, 22.6,
21.8, 21.7; HRMS (ESI-TOF) m/z: [M + H]+ and [M + Na]+ Calcd




a stirred solution of the tosylhydrazone 13 (822 mg, 1.9 mmol) in a
mixture of 1:1 THF-MeOH (15.2 mL) was added a trace of methyl
orange (indicator) and sodium cyanoborohydride (120 mg, 1.9
mmol). Subsequently, methanolic HCl (2 M) was added dropwise
keeping the color of the solution at the red-yellow transition point
(orange, pH ∼ 3.8). The mixture was stirred at room temperature for
1 h. A second portion of sodium cyanoborohydride (60 mg, 0.95
mmol) was added, followed by the dropwise addition of methanolic
HCl (2 M) to maintain the pH at ∼3.8. The mixture was then stirred
at room temperature at pH ∼ 3.8 for 1 h. NaHCO3 was added to the
mixture until pH ∼ 7, ﬁltered, and concentrated in vacuo at 40 °C.
The residue was puriﬁed by ﬂash chromatography on a 24 g silica
cartridge with DCM/MeOH, and increasing the ratio of MeOH from
0% to 4% in 22 min, the product eluted at 3% of MeOH to aﬀord a
yellow oil (519 mg, 64%). 1H NMR (400 MHz, methanol-d4) δ 7.81
(d, J = 8.1 Hz, 2H), 7.47 (d, J = 8.5 Hz, 1H, −SO2NH−), 7.42 (d, J =
8.0 Hz, 2H), 4.78 (d, J = 3.6 Hz, 1H), 3.93 (dt, J = 8.5, 4.3 Hz, 1H),
3.87−3.77 (m, 2H), 3.67 (dd, J = 11.7, 4.5 Hz, 1H), 3.63−3.56 (m,
2H), 3.18 (t, J = 3.8 Hz, 1H), 2.44 (s, 3H), 2.03 (s, 3H), 1.06 (d, J =
6.2 Hz, 3H), 1.04 (d, J = 6.1 Hz, 3H); 13C{1H} NMR (101 MHz,
methanol-d4) δ 172.8, 145.6, 137.2, 130.9, 129.2, 96.1, 71.2, 69.9,
69.0, 63.7, 62.9, 50.4, 23.8, 22.9, 21.64, 21.59. HRMS (ESI-TOF) m/
z: ([M − H]− Calcd for C18H28N3O7S 430.1643; found: 430.1655.
Isopropyl 2-Acetamido-2,3-dideoxy-α-D-ribo-hexopyranoside
(15). A mixture of the tosylhydrazine 14 (405 mg, 0.94 mmol) and
sodium acetate trihydrate (511 mg, 3.75 mmol) in 11 mL of ethanol
was reﬂuxed for 3 h. Ethanol was removed in vacuo, and the residue
was puriﬁed by ﬂash chromatography on a 15 g silica cartridge with
DCM/MeOH, increasing ratio of MeOH from 0 to 10% in 20 min,
the product eluted at 5% MeOH to provide a white solid (154 mg,
66%), m.p.: 164−166 °C; 1H NMR (400 MHz, methanol-d4) δ 4.83
(d, J = 3.6 Hz, 1H), 4.02−3.88 (m, 2H), 3.79 (dd, J = 11.7, 2.0 Hz,
1H), 3.65 (dd, J = 11.7, 5.0 Hz, 1H), 3.60−3.49 (m, 2H), 1.94 (s,
3H), 1.93−1.88 (m, 1H), 1.78 (dt, J = 12.7, 10.8 Hz, 1H), 1.25 (d, J =
6.3 Hz, 3H), 1.13 (d, J = 6.1 Hz, 3H); 13C{1H} NMR (101 MHz,
methanol-d4) δ 172.9, 95.3, 74.7, 70.7, 66.4, 63.0, 49.3, 34.0, 23.8,
22.6, 21.9. HRMS (ESI-TOF) m/z: [M + H]+ and [M + Na]+ Calcd
for C11H22NO5 248.1493 and C11H21NO5Na 270.1317; found
248.1494 and 270.1314.
D-Lividosamine (16). Isopropyl 2-acetamido-2,3-dideoxy-α-D-ribo-
hexopyranoside 15 (143 mg, 0.58 mmol) was dissolved in HCl (aq)
(2 M, 0.7 mL) and heated at 100 °C for 2 h. Subsequent evaporation
of the volatiles provided the product (107 mg, 92%) as a brown syrup.
In order to obtain NMR spectra with sharp signals, an analytical
sample was dissolved in water, followed by the addition of activated
carbon. After ﬁltration and evaporation, the NMR spectra were
obtained in DMSO-d6. The
1H NMR spectrum shows a major
anomeric signal at δ 5.12 ppm, being the α-pyranose of D-
lividosamine. C4-OH and C6-OH are too broad and are diﬃcult to
observe in the 1H NMR spectrum. Characterization matches the
literature.26 1H NMR (400 MHz, DMSO-d6) δ 8.18−8.00 (m, 3H,
C2-NH2HCl), 7.12 (d, J = 4.2 Hz, 1H, C1-OH), 5.12 (d, J = 2.9 Hz,
1H, H-1 for α-isomer), 3.62−3.56 (m, 1H, H-6b), 3.53−3.44 (m, 2H,
H-5, H-6a), 3.39−3.31 (m, 1H, H-4), 3.15−3.04 (m, 1H, H-2), 2.03−
1.96 (m, 1H, H-3b), 1.65 (q, J = 11.8 Hz, 1H, H-3a); 13C{1H} NMR
(101 MHz, DMSO-d6) δ 87.5, 73.2, 63.6, 60.7, 48.3, 31.1. HRMS
(ESI-TOF) m/z: [M + H]+ C6H14NO4 164.0917; found 164.0916.
E/Z-Isopropyl 2-Acetamido-2-deoxy-3-O-methyloxime-α-D-ribo-
hexapyranoside (17). Isopropyl 2-acetamido-2-deoxy-α-D-ribo-hex-
apyranoside-3-uloside 7 (1.57 g, 6.01 mmol), methoxyamine
hydrochloride (753 mg, 9.01 mmol), NaHCO3 (757 mg, 9.01
mmol), and anhydrous Na2SO4 (128 mg, 0.9 mmol) were heated in
anhydrous methanol (35 mL) at reﬂux for 2 h, and subsequently the
reaction mixture was stirred at room temperature for 2 days.
Evaporation of the solvent provided an oily residue, which was
puriﬁed by ﬂash chromatography on a 24 g silica cartridge with
DCM/MeOH, and increasing ratio of MeOH from 0 to 4% in 22 min,
the product eluted at 3% to provide an oil (1.58 g, 96% as a mixture of
E/Z isomers). The ratio of E and Z is approximately 1:1; 1H NMR
(400 MHz, methanol-d4) Mixture of E and Z isomers: δ 5.03 (d, J =
3.8 Hz, 1H), 4.95 (d, J = 3.8 Hz, 1H), 4.83 (m, 1H, overlap with H2O
in CD3OD), 4.65 (d, J = 3.9 Hz, 1H), 4.45 (d, J = 9.0 Hz, 1H), 4.10
(dt, J = 8.5, 3.1 Hz, 1H), 4.00−3.92 (m, 2H), 3.91−3.86 (m, 1H),
3.88 (s, 3H), 3.85 (s, 3H), 3.80−3.70 (m, 5H), 2.01 (s, 3H), 1.98 (s,
3H), 1.24 (d, J = 6.2 Hz, 3H), 1.23 (d, J = 6.3 Hz, 3H), 1.16 (d, J =
6.0 Hz, 3H), 1.15 (d, J = 6.0 Hz, 3H); 13C{1H} NMR (101 MHz,
methanol-d4) Mixture of E and Z isomers: δ 173.2, 173.0, 153.2,
151.9, 97.5, 96.8, 77.5, 75.4, 71.7, 71.4, 69.6, 69.2, 63.2, 63.1, 62.7,
62.4, 54.3, 53.3, 23.63, 23.58, 22.7, 22.5, 21.8, 21.6. HRMS (ESI-
TOF) m/z: [M + H]+ and [M + Na]+ Calcd for C12H23N2O6




hexapyranoside 17 (1.5 g, 5.45 mmol) in acetic acid (26 mL) was
hydrogenated over platinum(IV) oxide (124 mg, 0.55 mmol, 10 mol
%) under hydrogen pressure (5 bar) for 24 h. The reaction mixture
was ﬁltered over a short path of Celite, and the ﬁltrate was
concentrated in vacuo. Puriﬁcation by Grace ﬂash on a 15 g silica
cartridge with DCM/MeOH, and increasing ratio of MeOH from 0 to
20% in 20 min, the product eluted at 8% MeOH to aﬀord a colorless
oil (1.14 g, 80%); 1H NMR (400 MHz, methanol-d4) δ 4.95 (d, J =
3.6 Hz, 1H), 4.15 (t, J = 3.8 Hz, 1H), 3.96 (p, J = 6.2 Hz, 1H), 3.87−
3.81 (m, 1H), 3.80−3.69 (m, 3H), 3.44 (t, J = 4.0 Hz, 1H), 2.03 (s,
3H), 1.29 (d, J = 6.2 Hz, 3H), 1.19 (d, J = 6.1 Hz, 3H); 13C{1H}
NMR (101 MHz, methanol-d4) δ 173.4, 96.8, 72.5, 69.3, 65.8, 62.7,
54.3, 50.2, 23.7, 22.8, 21.7. HRMS (ESI-TOF) m/z: [M + H]+ and
[M + Na]+ Calcd for C11H23N2O5 263.1602 and C11H22N2O5Na
285.1426; found 263.1605 and 285.1423;
Isopropyl 2,3-Diamino-2,3-dideoxy-α-D-allopyranoside (19). Iso-
propyl 2-acetamido-3-amino-2,3-dideoxy-α-D-allopyranoside 18 (1.07
g, 4.08 mmol) was dissolved in aqueous NaOH (1 M, 8.6 mL). The
solution was heated in the microwave for 90 min at 150 °C and then
cooled down, and the water evaporated. The crude product was
puriﬁed on a Scorpius Diol (OH) 48 g column using DCM/MeOH,
and increasing ratio of MeOH from 0 to 30% in 30 min, the product
eluted at 5% MeOH to aﬀord a yellow oil (764 mg, 85%); 1H NMR
(400 MHz, methanol-d4) δ 4.82 (d, J = 3.7 Hz, 1H), 3.92 (p, J = 6.2
Hz, 1H), 3.83 (dd, J = 11.6, 2.4 Hz, 1H), 3.69 (dd, J = 11.6, 5.5 Hz,
1H), 3.65−3.60 (m, 1H), 3.52−3.46 (m, 1H), 3.04 (t, J = 4.1 Hz,
1H), 2.85−2.80 (m, 1H), 1.25 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 6.1
Hz, 3H); 13C{1H} NMR (101 MHz, methanol-d4) δ 99.8, 71.8, 68.9,
68.4, 63.2, 56.4, 52.7, 24.1, 21.9; HRMS (ESI-TOF) m/z: [M + H]+
and [M + Na]+ Calcd for C9H21N2O4 221.1496 and C9H20N2NaO4
243.1321; found 221.1495 and 243.1314.
(3aR,4S,6R,7S,7aS)-2-(4-Bromophenyl)-6-(hydroxymethyl)-4-iso-
propoxy-3,3a,4,6,7,7a-hexahydropyrano[3,4-d]imidazol-7-ol (20).
A solution of 4-bromobenzaldehyde (184 mg, 0.996 mmol) in tert-
butyl alcohol (10.9 mL) and isopropyl 2,3-diamino-2,3-dideoxy-α-D-
allopyranoside 19 (241 mg, 1.094 mmol) were mixed and stirred at
room temperature for overnight. Subsequently, N-iodosuccinimide
(246 mg, 1.09 mmol) was added to the mixture at room temperature
and stirred for 2 h. Sat. aq NaHCO3 was added to the reaction
mixture. The mixture was extracted with CHCl3. The organic layer
was dried over MgSO4 and evaporated in vacuo. The residue was
puriﬁed by ﬂash chromatography on a 15 g silica cartridge with DCM
(DCM contains 0.25% Et3N)/MeOH, and increasing the ratio of
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MeOH from 0 to 5% in 22 min, the product eluted at 4% MeOH to
provide a yellow crystalline solid (216 mg, 51%), mp 178−182 °C; 1H
NMR (400 MHz, Methanol-d4) δ 7.79 (s, 4H), 5.08 (d, J = 4.2 Hz,
1H), 4.64 (dd, J = 9.8, 4.8 Hz, 1H), 4.44 (dd, J = 9.8, 4.2 Hz, 1H),
4.12 (dd, J = 9.5, 4.9 Hz, 1H), 4.00 (p, J = 6.2 Hz, 1H), 3.88−3.75
(m, 3H), 1.16 (d, J = 6.2 Hz, 3H), 1.11 (d, J = 6.1 Hz, 3H); 13C{1H}
NMR (101 MHz, methanol-d4) δ 168.9, 133.8, 131.2, 129.9, 124.9,
94.0, 72.3, 71.8, 63.6, 63.4, 62.9, 60.9, 23.8, 21.9. HRMS (ESI-TOF)
m/z: [M + H]+ Calcd for C16H22BrN2O4 385.0758 and 387.0737;
found 385.0760 and 387.0734.
(4S,6R,7S)-2-(4-Bromophenyl)-6-(hydroxymethyl)-4-isopropoxy-
3,4,6,7-tetrahydropyrano [3, 4-d] imidazol-7-ol (21). To a mixture
of 20 (193 mg, 0.5 mmol) and K2CO3 (76 mg, 0.55 mmol) in DMSO
(5 mL) was added PhI(OAc)2 (177 mg, 0.55 mmol). Then the
mixture was stirred for 24 h at room temperature under an N2
atomosphere. After the reaction completed, water (50 mL) was
added, and the mixture was lyophilized to aﬀord the crude product.
Subsequent puriﬁcation by ﬂash chromatography on a 4 g silica
cartridge with pentane/EtOAc, and increasing ratio of EtOAc from 0
to 90% in 15 min, the product eluted at 88% EtOAc to provide a
white amorphous solid (81 mg, 42%); 1H NMR (400 MHz,
methanol-d4) δ 7.80 (d, J = 8.3 Hz, 2H), 7.60 (d, J = 8.3 Hz, 2H),
5.71 (s, 1H), 4.69 (d, J = 9.0 Hz, 1H), 4.20 (p, J = 6.2 Hz, 1H), 4.01−
3.91 (m, 2H), 3.82 (dd, J = 11.9, 5.6 Hz, 1H), 1.30 (d, J = 6.0 Hz,
3H), 1.29 (d, J = 6.0 Hz, 3H); 13C{1H} NMR (101 MHz, methanol-
d4) δ 147.6, 133.2, 130.7, 128.5, 124.0, 94.3, 75.7, 71.6, 63.8, 62.5,
24.2, 22.4; HRMS (ESI-TOF) m/z: [M-H]− Calcd for C16H18BrN2O4





benzoate (22a and 22b). To a stirred suspension of isopropyl 2-
acetamido-2-deoxy-α-D-ribo- hexapyranoside-3-uloside 7 (130 mg, 0.5
mmol) in DCM/THF (1:1, 0.5 mL, 1 M) were added benzoic acid
(61 mg, 0.5 mmol) and benzyl isocyanide (61 μL, 0.5 mmol). The
reaction was allowed to stir at room temperature for 5 days, then
concentrated in vacuo, and separated by ﬂash chromatography on a
12 g silica cartridge with pentane/EtOAc, and increasing ratio of
EtOAc from 0 to 100%, 22a eluted at 77% EtOAc as colorless oil (74
mg, 30%) and 22b eluted at 90% EtOAc as white amorphous solid
(89 mg, 36%).
22a. 1H NMR (400 MHz, methanol-d4) δ 8.01−7.97 (m, 2H),
7.64−7.58 (m, 1H), 7.50−7.41 (m, 4H), 7.38−7.33 (m, 2H), 7.31−
7.24 (m, 1H), 4.99 (d, J = 3.6 Hz, 1H), 4.82 (d, J = 3.6 Hz, 1H), 4.65
(d, J = 14.9 Hz, 1H), 4.35 (d, J = 14.9 Hz, 1H), 4.32 (d, J = 10.1 Hz,
1H), 4.14 (ddd, J = 10.1, 4.7, 2.5 Hz, 1H), 3.92 (p, J = 6.2 Hz, 1H),
3.85 (dd, J = 12.0, 2.6 Hz, 1H), 3.79 (dd, J = 11.9, 4.7 Hz, 1H), 1.97
(s, 3H), 1.13 (d, J = 6.2 Hz, 3H), 1.10 (d, J = 6.0 Hz, 3H); 13C{1H}
NMR (101 MHz, methanol-d4) δ 173.2, 169.9, 167.2, 139.4, 134.7,
131.6, 131.1, 129.8, 129.7, 129.1, 128.6, 96.9, 84.5, 73.4, 71.9, 71.9,
62.7, 55.6, 44.9, 23.6, 23.1, 21.7; HRMS (ESI-TOF) m/z: [M + H]+
and [M + Na]+ Calcd for C26H33N2O8 501.2231 and C26H32N2O8Na
523.2056; found 501.2235 and 523.2054;
22b. 1H NMR (400 MHz, methanol-d4) δ 8.03 (d, J = 7.6 Hz, 2H),
7.64 (t, J = 7.5 Hz, 1H), 7.47 (t, J = 7.7 Hz, 2H), 7.07−7.02 (m, 3H),
7.00−6.94 (m, 2H), 5.57 (d, J = 10.5 Hz, 1H), 5.08 (d, J = 3.9 Hz,
1H), 4.58 (d, J = 3.9 Hz, 1H), 4.28 (d, J = 15.0 Hz, 1H), 4.23 (d, J =
14.7 Hz, 1H), 4.19 (ddd, J = 10.5, 5.1, 3.5 Hz, 1H), 4.03 (p, J = 6.2
Hz, 1H), 3.68−3.59 (m, 2H), 1.91 (s, 3H), 1.33 (d, J = 6.2 Hz, 3H),
1.19 (d, J = 6.1 Hz, 3H); 13C{1H} NMR (101 MHz, methanol-d4) δ
173.0, 171.9, 166.6, 139.8, 134.8, 131.2, 130.9, 129.8, 129.4, 128.4,
128.1, 97.1, 79.6, 72.9, 71.4, 68.9, 62.9, 53.0, 44.1, 23.7, 22.5, 21.7;
HRMS (ESI-TOF) m/z: [M + H]+ and [M + Na]+ Calcd for




(23). To a solution of 22 in methanol (0.05 M) was added sodium
methoxide (1.2 equiv) at room temperature. The reaction was stirred
at room temperature for 3 h, then concentrated in vacuo, and puriﬁed
by ﬂash chromatography on a 4 g silica cartridge with DCM/MeOH,
and increasing ratio of MeOH from 0 to 15%, the product eluted at
10% MeOH to aﬀord a colorless oil.
Obtained 23 from 22a on a 0.116 mmol scale; yield: 36 mg (78%).
Obtained 23 from 22b on a 0.136 mmol scale; yield: 46 mg (85%).
HRMS (ESI-TOF) m/z: [M − H]− Calcd for C19H27N2O7 395.1813;
found 395.1825. 1H NMR (400 MHz, methanol-d4) δ 7.41−7.24 (m,
5H), 4.94 (d, J = 4.4 Hz, 1H), 4.61 (d, J = 14.7 Hz, 1H), 4.33 (d, J =
14.7 Hz, 1H), 4.26 (d, J = 4.4 Hz, 1H), 4.02 (ddd, J = 10.4, 5.3, 2.5
Hz, 1H), 3.90 (p, J = 6.2 Hz, 1H), 3.82 (dd, J = 11.9, 2.5 Hz, 1H),
3.72 (dd, J = 11.9, 5.3 Hz, 1H), 3.66 (d, J = 10.4 Hz, 1H), 1.96 (s,
3H), 1.04 (d, J = 6.1 Hz, 3H), 1.02 (d, J = 6.2 Hz, 3H); 13C{1H}
NMR (101 MHz, methanol-d4) δ 173.8, 172.3, 139.7, 129.8, 129.2,
128.6, 96.4, 78.9, 74.5, 72.5, 72.1, 63.0, 56.8, 44.7, 23.3, 22.8, 21.6.
tert-Butyl (Z)-2-((2S,3R,5S,6R)-3-Acetamido-5-hydroxy-6-(hy-
droxymethyl)-2-isopropoxytetrahydro-4H-pyran-4-ylidene)-
hydrazine-1-carboxylate (24). 1H NMR (400 MHz, methanol-d4) δ
8.36 (d, J = 7.0 Hz, 1H), 5.20 (d, J = 3.5 Hz, 1H), 4.56 (d, J = 9.8 Hz,
1H), 4.48 (dd, J = 7.0, 3.5 Hz, 1H), 3.91−3.85 (m, 2H), 3.80−3.72
(m, 2H), 2.04 (s, 3H), 1.51 (s, 9H), 1.19 (d, J = 6.3 Hz, 3H), 1.10 (d,
J = 6.1 Hz, 3H). 13C{1H} NMR (101 MHz, methanol-d4) δ 173.2,
155.8, 145.2, 97.7, 82.5, 75.9, 73.5, 72.1, 62.0, 56.0, 28.7, 23.7, 22.4,
22.0. HRMS (ESI-TOF) m/z: [M + H]+ and [M + Na]+ Calcd for




The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.joc.8b01949.
Associated analytical data (1H NMR, 13C{1H} NMR for
all compounds (PDF)
Crystallographic data for 4 (CIF)
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